ScholarIQanswers from OpenAlex & ORCID
David M. Goldenberg
ResearcherPublications, citations & collaboration network
David M. Goldenberg is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David M. Goldenberg have?
ScholarIQindexed works
David M. Goldenberg has 1,138 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David M. Goldenberg have?
ScholarIQcitation count
David M. Goldenberg has 40,481 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David M. Goldenberg?
ScholarIQh-index
David M. Goldenberg has an h-index of 103 in OpenAlex.
What is the i10-index of David M. Goldenberg?
ScholarIQi10-index
David M. Goldenberg has an i10-index of 550 in OpenAlex.
What is the ORCID of David M. Goldenberg?
ScholarIQorcid
The ORCID for David M. Goldenberg is on the source record.
What is the OpenAlex record for David M. Goldenberg?
ScholarIQopenalex
The OpenAlex for David M. Goldenberg is on the source record.
What are the most-cited papers on David M. Goldenberg?
ScholarIQmost cited works
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam Brufsky, Sagar Sardesai, Kevin Kalinsky, Amelia Zelnak, Robert Weaver, Tiffany A. Traina, Florence Dalenc, Philippe Aftimos, Filipa Lynce, Sami Diab, Javier Cortés, Joyce O’Shaughnessy, Véronique Dièras, Cristiano Ferrario, Peter Schmid, Lisa A. Carey, Luca Gianni, Martine Piccart, Sibylle Loibl, David M. Goldenberg, Quan Hong, Martin Olivo, Loretta M. Itri, Hope S. Rugo
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat, Sara M. Tolaney, Steven J. Isakoff, Jennifer R. Diamond, Joyce O’Shaughnessy, Rebecca Moroose, Alessandro D. Santin, Vandana G. Abramson, Nikita Shah, Hope S. Rugo, David M. Goldenberg, Ala M. Sweidan, Robert Iannone, Sarah A. Washkowitz, Robert M. Sharkey, William A. Wegener, Kevin Kalinsky
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Aditya Bardia, Sara M. Tolaney, Kevin Punie, Delphine Loirat, Mafalda Oliveira, Kevin Kalinsky, Amelia Zelnak, Philippe Aftimos, Florence Dalenc, Sagar Sardesai, Erika Hamilton, Priyanka Sharma, Sabela Recalde, Eva Ciruelos Gil, T Traina, Joyce O’Shaughnessy, Javier Cortés, Mu‐Hung Tsai, Linda T. Vahdat, Véronique Dièras, Lisa A. Carey, Hope S. Rugo, David M. Goldenberg, Q. Hong, Martin Olivo, Loretta M. Itri, Sara A. Hurvitz